↓ Skip to main content

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Overview of attention for article published in New England Journal of Medicine, June 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Readers on

mendeley
952 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 311 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 952 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 952 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 126 13%
Other 85 9%
Student > Ph. D. Student 76 8%
Student > Doctoral Student 69 7%
Student > Bachelor 65 7%
Other 159 17%
Unknown 372 39%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 309 32%
Biochemistry, Genetics and Molecular Biology 80 8%
Agricultural and Biological Sciences 30 3%
Immunology and Microbiology 28 3%
Pharmacology, Toxicology and Pharmaceutical Science 25 3%
Other 59 6%
Unknown 421 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 836. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2026.
All research outputs
#27,721
of 34,637,473 outputs
Outputs from New England Journal of Medicine
#1,069
of 38,549 outputs
Outputs of similar age
#465
of 374,862 outputs
Outputs of similar age from New England Journal of Medicine
#22
of 277 outputs
Altmetric has tracked 34,637,473 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 38,549 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 120.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 374,862 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 277 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.